Former Done Global CEO, Clinical President Sentenced in Telehealth Adderall Fraud Case

Key Takeaways

• Former Done Global executives sentenced: A federal court sentenced the company's founder and former CEO to 8 years in prison and its former clinical president to 6 years and 6 months following convictions related to unlawful controlled substance distribution and health care fraud.
• Telehealth prescribing practices at issue: According to the US Department of Justice (DOJ), the defendants used the company's telehealth platform to prescribe Adderall and other stimulant medications without a legitimate medical purpose while pressuring clinicians to increase prescribing.
• Case highlights telehealth enforcement: Prosecutors alleged the scheme also caused false reimbursement claims to be submitted to Medicare, Medicaid, and commercial insurers. The case underscores continued federal scrutiny of controlled substance prescribing through telehealth platforms.

The founder and former chief executive officer of Done Global Inc and the company's former clinical president have been sentenced in federal court for their roles in what the DOJ described as a scheme to unlawfully distribute Adderall and other stimulant medications through a telehealth platform and to commit health care fraud.

Ruthia He, founder and former CEO of Done Global Inc, was sentenced to 8 years in prison. David Brody, MD, the company's former clinical president, was sentenced to 6 years and 6 months in prison. According to the DOJ, the court also ordered forfeiture of approximately $29 million from He and approximately $4 million from Brody. Combined with forfeiture and financial penalties imposed on other co-conspirators, the total financial recovery exceeds $90 million.

Telehealth Prescribing Scheme

According to the DOJ, He and Brody operated Done Global as an online platform that issued prescriptions for Adderall and other stimulant medications without a legitimate medical purpose.

Federal prosecutors said the company used deceptive advertising to recruit patients seeking stimulant medications and designed its business model to maximize prescriptions. According to the DOJ, clinicians were encouraged to prescribe controlled substances following brief online appointments and were monitored based on prescribing activity. Prosecutors also alleged that clinicians who raised concerns or referred patients for additional psychiatric evaluation faced pressure to continue prescribing.

The DOJ stated that the defendants took advantage of expanded telemedicine flexibilities implemented during the COVID-19 public health emergency to increase access to Schedule II stimulant medications through the platform.

Health Care Fraud Allegations

In addition to unlawful prescribing, prosecutors alleged that the defendants participated in a conspiracy to commit health care fraud by causing false reimbursement claims for stimulant medications to be submitted to Medicare, Medicaid, and commercial insurance plans.

According to the DOJ, the prescribing practices generated millions of dollars in revenue while resulting in improper reimbursement payments by government health care programs and private insurers.

Convictions and Sentencing

The sentences follow convictions returned by a federal jury. According to the DOJ, He was convicted of conspiracy to unlawfully distribute controlled substances, conspiracy to commit health care fraud, and conspiracy to obstruct justice. Brody was convicted of conspiracy to unlawfully distribute controlled substances and conspiracy to commit health care fraud.

The DOJ also noted that several former executives and clinicians associated with the company previously pleaded guilty in connection with the investigation.

Enforcement Focus on Telehealth

Federal officials described the prosecution as part of broader efforts to address the unlawful prescribing of controlled substances through telehealth platforms while preserving access to legitimate virtual care.

The case was investigated by the Drug Enforcement Administration, the Department of Health and Human Services Office of Inspector General, the Federal Bureau of Investigation, and Internal Revenue Service Criminal Investigation.

Reference

Founder/CEO and clinical president of digital health company sentenced to 72 months and 24 months, respectively, for $90 million scheme to distribute over 37 million pills of Adderall. US Department of Justice. Press release. Published July 7, 2026. Accessed July 8, 2026. https://www.justice.gov/opa/pr/telemedicine-company-owner-and-author-health-care-compliance-books-sentenced-136m-medicare